KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to $296.6 million.

  • Gsk's Change in Taxes fell 5030.44% to $296.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 2347.69%. This contributed to the annual value of $1.5 billion for FY2025, which is 11809.77% up from last year.
  • As of Q4 2025, Gsk's Change in Taxes stood at $296.6 million, which was down 5030.44% from $420.9 million recorded in Q3 2025.
  • In the past 5 years, Gsk's Change in Taxes registered a high of $642.9 million during Q4 2023, and its lowest value of -$95.0 million during Q2 2021.
  • For the 5-year period, Gsk's Change in Taxes averaged around $295.9 million, with its median value being $323.5 million (2023).
  • Per our database at Business Quant, Gsk's Change in Taxes plummeted by 13808.21% in 2021 and then soared by 3249458.74% in 2025.
  • Over the past 5 years, Gsk's Change in Taxes (Quarter) stood at -$62.0 million in 2021, then surged by 994.71% to $554.8 million in 2022, then increased by 15.88% to $642.9 million in 2023, then decreased by 7.17% to $596.8 million in 2024, then tumbled by 50.3% to $296.6 million in 2025.
  • Its Change in Taxes stands at $296.6 million for Q4 2025, versus $420.9 million for Q3 2025 and $321.5 million for Q2 2025.